Grace Therapeutics, Inc. (GRCE) › Cost of RevenueGrace Therapeutics, Inc. (GRCE) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2021: $76.0K2022: $0$02021Cost of Revenue (USD)2022Fiscal YearCost of RevenueChange YoY2022$0-100.0%2021$76.0K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share